Literature DB >> 23563934

Calcium supplements and cardiovascular risk in the Women's Health Initiative.

M J Bolland, A Grey, I R Reid.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23563934     DOI： 10.1007/s00198-013-2356-z

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  6 in total

1.  Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women's Health Initiative (WHI) limited-access data set.

Authors:  Mark J Bolland; Andrew Grey; Greg D Gamble; Ian R Reid
Journal:  Am J Clin Nutr       Date:  2011-08-31       Impact factor: 7.045

2.  The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease.

Authors:  Joann E Manson; Shari S Bassuk; I-Min Lee; Nancy R Cook; Michelle A Albert; David Gordon; Elaine Zaharris; Jean G Macfadyen; Eleanor Danielson; Jennifer Lin; Shumin M Zhang; Julie E Buring
Journal:  Contemp Clin Trials       Date:  2011-10-02       Impact factor: 2.226

3.  Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial.

Authors:  Joan M Lappe; Dianne Travers-Gustafson; K Michael Davies; Robert R Recker; Robert P Heaney
Journal:  Am J Clin Nutr       Date:  2007-06       Impact factor: 7.045

Review 4.  Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis.

Authors:  Mark J Bolland; Alison Avenell; John A Baron; Andrew Grey; Graeme S MacLennan; Greg D Gamble; Ian R Reid
Journal:  BMJ       Date:  2010-07-29

Review 5.  Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis.

Authors:  Mark J Bolland; Andrew Grey; Alison Avenell; Greg D Gamble; Ian R Reid
Journal:  BMJ       Date:  2011-04-19

6.  Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study.

Authors:  R L Prentice; M B Pettinger; R D Jackson; J Wactawski-Wende; A Z Lacroix; G L Anderson; R T Chlebowski; J E Manson; L Van Horn; M Z Vitolins; M Datta; E S LeBlanc; J A Cauley; J E Rossouw
Journal:  Osteoporos Int       Date:  2012-12-04       Impact factor: 4.507
  6 in total
  4 in total

1.  Calcium supplements and cardiovascular risk in the Women's Health Initiative: response to Bolland et al.

Authors:  R L Prentice; R D Jackson; J E Rossouw
Journal:  Osteoporos Int       Date:  2013-04-06       Impact factor: 4.507

Review 2.  Cancer-associated bone disease.

Authors:  R Rizzoli; J-J Body; M-L Brandi; J Cannata-Andia; D Chappard; A El Maghraoui; C C Glüer; D Kendler; N Napoli; A Papaioannou; D D Pierroz; M Rahme; C H Van Poznak; T J de Villiers; G El Hajj Fuleihan
Journal:  Osteoporos Int       Date:  2013-10-22       Impact factor: 4.507

3.  Physicians' attitudes to contemporary issues on osteoporosis management in Korea.

Authors:  Yong-Chan Ha; Young-Kyun Lee; Yong-Taik Lim; Sun-Mee Jang; Chan Soo Shin
Journal:  J Bone Metab       Date:  2014-05-31

Review 4.  Public health impact and cost-effectiveness of dairy products supplemented with vitamin D in prevention of osteoporotic fractures.

Authors:  Olivier Ethgen; Mickaël Hiligsmann; Nansa Burlet; Jean-Yves Reginster
Journal:  Arch Public Health       Date:  2015-12-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.